Visitors Now:
Total Visits:
Total Stories:
Profile image
By DecisionDatabases
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Nuclear Medicine Market: Global Industry Analysis and Forecasts 2015-2022

Thursday, December 1, 2016 1:25
% of readers think this story is Fact. Add your two cents.

(Before It's News)

DecisionDatabases.com offers Nuclear Medicine Market Research Report. This Report covers the complete Industry Outlook, Growth, Size, Share and Forecast Till 2022.

Get Free Sample Copy @ http://www.decisiondatabases.com/contact/download-sample-8182

The global nuclear medicine/radiopharmaceuticals market research report provides detailed information about the industry based on the revenue (USD MN) for the forecast period. The research study is a descriptive analysis of this market emphasizing the market drivers and restraints that govern the overall market growth. The trends and future prospects for the market are also included in the report which gives an intellectual understanding of the nuclear medicine/radiopharmaceuticals industry. Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period.

A glimpse of the major drivers and restraints affecting this market is mentioned below:

A. Drivers
> Increase in the number of new cancer cases
> Rising adoption of SPECT and PET Scans
> Increase in preference for radiation therapy for cancer treatment
> Developments in imaging technologies using radiopharmaceuticals

B. Restraints
> Stringent regulatory policies
> Competition from conventional alternative diagnostic procedures

The report offers a value chain analysis that gives a comprehensive outlook of the nuclear medicine/radiopharmaceuticals market. The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.

The nuclear medicine/radiopharmaceuticals market has been segmented based on product types such as diagnostic and therapeutic products. Diagnostics products market is further analyzed based on SPECT and PET isotopes. Whereas, therapeutics market is divided into alpha emitters, beta emitters, and brachytherapy. The study incorporates periodic market estimates and forecasts. Each product type has been analyzed based on the market size at regional and country levels.

The nuclear medicine/radiopharmaceuticals market has been segmented based on cardiology, neurology, oncology, thyroid, bone metastasis, and endocrine tumors. The report provides forecast and estimates for each application in terms of market size during the study period. Each application has been further analyzed based on regional and country levels.

Geographically, the nuclear medicine/radiopharmaceuticals market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The study details country-level aspects based on each segment and gives estimates in terms of market size.

Access full report at: http://www.decisiondatabases.com/ip/8182-nuclear-medicine-radiopharmaceuticals-market-report

The report also studies the competitive landscape of the global market with company profiles of players such as Cardinal Health, Inc., GE Healthcare, Eczacibasi-Monrol Nuclear Products, Bayer Healthcare AG, IBA Molecular Imaging, Mallinckrodt plc, and Sigma Aldrich Corporation, Medtronic plc, Nordien, Inc., Jubilant Pharma, and Siemens Healthcare. A detailed description of each has been included, with information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments. This analysis gives a thorough idea about the competitive positioning of market players. The report also gives information of nuclear medicine/radiopharmaceuticals market’s mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.

Major Table Of Contents:

1. INTRODUCTION
2. EXECUTIVE SUMMARY 
3. MARKET ANALYSIS OF NUCLEAR MEDICINE/RADIOPHARMACEUTICALS
4. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET ANALYSIS BY PRODUCT TYPE
5. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
6. NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET ANALYSIS BY GEOGRAPHY
7. COMPETITIVE LANDSCAPE OF NUCLEAR MEDICINE/RADIOPHARMACEUTICALS COMPANIES
8. COMPANY PROFILES OF NUCLEAR MEDICINE/RADIOPHARMACEUTICALS INDUSTRY

Purchase Complete Global Nuclear Medicine / Radiopharmaceuticals Market Research Report At: http://www.decisiondatabases.com/contact/buy-now-8182

About Us:

DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.

Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.

For more details:
DecisionDatabases.com
E-Mail: sales@decisiondatabases.com
Phone: +91 99 28 237112
Web: www.decisiondatabases.com
Blog: blog.decisiondatabases.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.